iifl-logo-icon 1
iifl-logo-icon 1
iifl-logo-icon 1
Home

Par Drugs & Chemicals Ltd Board Meeting

₹240.19
(-1.48%)
Jul 5, 2024|12:00:00 AM

Par Drugs & Che. CORPORATE ACTIONS

08/07/2023calendar-icon
07/07/2024calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting9 May 202429 Apr 2024
To consider other business matters. Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 09, 2024. Par Drugs And Chemicals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2024. (As Per NSE Announcement Dated on: 09/05/2024)
Board Meeting7 Mar 202428 Feb 2024
To consider other business matters Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on March 07, 2024. (As Per NSE Announcement Dated on: 07/03/2024)
Board Meeting16 Feb 20246 Feb 2024
To consider and approve the financial results for the period ended December 31, 2023 and other business matters PAR : 16-Feb-2024 : The Company has informed the Exchange that a Board meeting to be held on February 14, 2024 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on February 16, 2024, To consider and approve the financial results for the period ended December 31, 2023 and other business matters (As Per NSE Announcement Dated on: 08/02/2024) Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on February 16, 2024. (As Per NSE Announcement Dated on: 16/02/2024)
Board Meeting28 Oct 202319 Oct 2023
To consider and approve the financial results for the period ended September 30, 2023 and other business matters Par Drugs And Chemicals Limited has informed the Exchange regarding Board meeting held on October 28, 2023. (As Per NSE Announcement Dated on: 28/10/2023)
Board Meeting17 Aug 20239 Aug 2023
To consider other business matters PAR DRUGS AND CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 17-Aug-2023 to consider Other business. Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 17, 2023. Par Drugs And Chemicals Limited has informed the Exchange regarding Board meeting held on August 17, 2023. (As Per NSE Announcement Dated on 17/08/2023)
Board Meeting3 Aug 202325 Jul 2023
To consider and approve the financial results for the period ended Jun 30, 2023 and other business matters PAR DRUGS AND CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 03-Aug-2023 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2023 and Other business. Par Drugs And Chemicals Limited has informed the Exchange regarding Unaudited Standalone Financial Results of the Company for the quarter ended on 30th June, 2023 along with Limited Review Report. Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 03, 2023. Par Drugs And Chemicals Limited has informed the Exchange regarding Board meeting held on August 03, 2023. Par Drugs And Chemicals Limited has submitted to the Exchange, the financial results for the period ended June 30, 2023. (As Per NSE Announcement Dated on 03/08/2023) Par Drugs And Chemicals Limited has informed the Exchange about Copy of Newspaper Publication Standalone Unaudited Financial Results for the quarter ended 30th June, 2023 (As Per NSE Announcement Dated on 04/08/2023)

Par Drugs & Che.: Related News

No record found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

QUICKLINKS FOR Par Drugs & Chemicals Ltd

Information
Share PriceFutures PriceOption Chain
Financials
Profit & LossBalance SheetCash FlowKey Ratios
Results
Quarterly ResultHalf Yearly ResultNine Monthly ResultAnnual Result
News
Company
Marketplus
Derivativesplus
IPOplus
Mutual Fundsplus
Calculatorsplus
Nifty 50plus
Companyplus
Loansplus
Knowledge Centerplus
Newsplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Marketplus
Derivativesplus
IPOplus
Mutual Fundsplus
Calculatorsplus
Nifty 50plus
Companyplus
Loansplus
Knowledge Centerplus
Newsplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

About
IIFL Group
Products & Services
Trading Documentation
Useful Links
ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.